Global Artificial Pancreas Device System Market 2019-2025HomeMailNewsFinanceSportsEntertainmentSearchMobileMoreYahooSearchNo matching results for ''Tip: Try a valid symbol or a specific company name for relevant resultsSign inMailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets open in 9 hrs 20 minsS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Global Artificial Pancreas Device System Market 2019-2025GlobeNewswireJanuary 10, 2020ReblogShareTweetShareDublin, Jan. 10, 2020 (GLOBE NEWSWIRE) -- The "Global Artificial Pancreas Device System Market 2019-2025" report has been added to ResearchAndMarkets.com's offering.
The global artificial pancreas device system market is estimated to grow impressively at a CAGR of 55% over the forecast period. The increasing prevalence of diabetes and its burden coupled with the rising need for advanced and innovative diabetic care devices is acting as a driving factor for the growth of the market. Moreover, increasing awareness among the population towards diabetes and the growing focus of organizations towards the efficacy and R&D of artificial pancreas device systems across the globe is also augmenting the market growth.Medtronic, Johnson & Johnson and Dexcom are the key market players working on the development of the artificial pancreas. Medtronic and Animas (J&J) have been successful in developing the first closed-loop system. As of November 2019, the artificial pancreas device systems are under development phase only and has not been commercialized in the market.The global artificial pancreas device system market is segmented on the basis of type and region. On the basis of type, the market is sub-segmented into a threshold suspended device system, insulin-only system, and bi-hormonal control system. The threshold suspended device system serves as a potential back-up when a patient is unable to respond to low blood sugar (hypoglycemia) event. Owing to this, the threshold suspended device system segment is poised to hold significant potential during the forecast period. Geographically, the market is analyzed into North America, Europe, Asia-Pacific, and the Rest of the World. North America held the dominating position in the global artificial pancreas device system market in 2018 and is further estimated to follow the same trend over the forecast period. The growth of the region is primarily backed by an increased focus on the development of the artificial pancreas system by the market players.Furthermore, the global artificial pancreas device system market is influenced by the presence of several players including Medtronic PLC, Johnson & Johnson Services Inc., Insulet Corp., Pancreum Inc., Tandem Diabetes Care Inc., and many others. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players.This report covers:Comprehensive research methodology of the global artificial pancreas device system market.A detailed and extensive market overview with key analyst insights.An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.Analysis of regional regulations and other government policies impacting the global artificial pancreas device system market.Insights about market determinants which are stimulating the global artificial pancreas device system market.Detailed and extensive market segments with regional distribution of forecasted revenues.Extensive profiles and recent developments of market players.Key Topics Covered
1. Report Summary1.1. Research Methods and Tools1.2. Market Breakdown1.2.1. By Segments1.2.2. By Geography2. Market Overview and Insights2.1. Scope of the Report 2.2. Analyst Insight & Current Market Trends2.2.1. Key Findings2.2.2. Recommendations2.2.3. Conclusion2.3. Rules & Regulations3. Competitive Landscape3.1. Company Share Analysis3.2. Key Strategy Analysis3.3. Key Company Analysis3.3.1. Medtronic PLC3.3.1.1. Overview3.3.1.2. Financial Analysis3.3.1.3. SWOT Analysis3.3.1.4. Recent Developments3.3.2. Johnson & Johnson Services Inc.3.3.3. Insulet Corp.3.3.4. Pancreum, Inc.3.3.5. Tandem Diabetes Care, Inc.4. Market Determinants4.1. Motivators4.2. Restraints4.3. Opportunities5. Market Segmentation5.1. Global Artificial Pancreas Device System Market by Type5.1.1. Threshold Suspended Device System5.1.2. Insulin-Only System5.1.3. Bi-Hormonal Control System 6. Regional Analysis6.1. North America6.1.1. United States6.1.2. Canada6.2. Europe6.2.1. UK6.2.2. Germany6.2.3. Italy6.2.4. Spain6.2.5. France6.2.6. Rest of Europe6.3. Asia-Pacific6.3.1. China6.3.2. Japan6.3.3. India6.3.4. Rest of Asia-Pacific6.4. Rest of the World7. Company Profiles7.1. Admetsys Corp.7.2. Beta Bionics7.3. Beta-O2 Technologies Ltd.7.4. Bigfoot Biomedical Inc.7.5. Companion Medical Inc.7.6. Defymed SAS7.7. Dexcom Inc. 7.8. Eli Lilly and Co.7.9. Inreda Diabetic BV7.10. Insulet Corp.7.11. Johnson & Johnson Services Inc.7.12. Medtronic PLC7.13. Pancreum, Inc.7.14. Tandem Diabetes Care, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/mr2540Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.Story continuesCONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoCrocs CEO explains its major turnaroundYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoWhat the GM strike means for the U.S. economyYahoo FinanceWhy negative interest rates are 'seriously dangerous': strategistYahoo FinanceAurora Cannabis tumbles after double downgradeYahoo Finance VideoCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoLoan growth will be a 'critical factor' in upcoming bank earnings: AnalystYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceU.S. airlines suspend flights over coronavirus fearsYahoo Finance VideoBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'Yahoo FinanceWhat to watch in the markets: Friday, February 28Yahoo Finance Video'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo Finance